Assessment of the Therapeutic Efficacy of Oncostatin M-preconditioned MSCs in the Bleomycin-induced Pulmonary Fibrosis Mouse Model
碩士 === 長庚大學 === 醫學生物技術暨檢驗學系 === 100 === Idiopathic pulmonary fibrosis (IPF) is characterized by an intricate cytokine network and abnormal deposition of mesenchymal cells. Recent studies indicated that Oncostatin M (OSM), a member of IL-6 family cytokine, was up-regulated in the bronchoalveolar lava...
Main Authors: | Si Min Theng, 鄧思敏 |
---|---|
Other Authors: | K. Y. Chong |
Format: | Others |
Published: |
2012
|
Online Access: | http://ndltd.ncl.edu.tw/handle/40288781243802172489 |
Similar Items
-
In vivo therapeutic success of MicroRNA-155 antagomir in a mouse model of pulmonary fibrosis induced by bleomycin
by: Xiaoyuan Sun, et al.
Published: (2021-03-01) -
Protective and therapeutic effect of felodipine against bleomycin-induced pulmonary fibrosis in mice
by: Ken-ichiro Tanaka, et al.
Published: (2017-06-01) -
Therapeutic effect of flaxseed oil on experimental pulmonary fibrosis induced by bleomycin in rats
by: Anouar Abidi, et al.
Published: (2016-08-01) -
Therapeutic Effects of the Bcl-2 Inhibitor on Bleomycin-induced Pulmonary Fibrosis in Mice
by: Yicheng He, et al.
Published: (2021-10-01) -
Macrophage hypoxia signaling regulates cardiac fibrosis via Oncostatin M
by: Hajime Abe, et al.
Published: (2019-06-01)